TY - JOUR
T1 - Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System Intervention
AU - Petrykiv, Sergei I.
AU - Laverman, Gozewijn Dirk
AU - Persson, Frederik
AU - Vogt, Liffert
AU - Rossing, Peter
AU - de Borst, Martin H.
AU - Gansevoort, Ronald T.
AU - de Zeeuw, Dick
AU - Heerspink, Hiddo J. L.
PY - 2017
Y1 - 2017
N2 - Background and objectives In the treatment of CKD, individual patients show a wide variation in their response to many drugs, including renin-angiotensin-aldosterone system inhibitors (RAASi). To investigate whether therapy resistance to RAASi can be overcome by uptitrating the dose of drug, changing the mode of intervention (with drugs from similar or different classes), or lowering dietary sodium intake, we meta-analyzed individual responses to different modes of interventions. Design, setting, participants, & measurements Randomized crossover trials were analyzed to assess correlation of individual responses to RAASi and nonsteroidal anti-inflammatory drugs (NSAIDs; n = 395 patients). Included studies compared the antialbuminuric effect of uptitrating the dose of RAASi (n = 10 studies) and NSAIDs (n = 1), changing within the same class of RAASi (e.g., angiotensin-converting enzyme inhibition to angiotensin receptor blockers; n = 5) or NSAIDs (n = 1), changing from RAASi to NSAIDs (n = 2), and changing from high to low sodium intake (n = 5). A two-stage meta-analysis was conducted: Deming regression was conducted in each study to assess correlations in response, and individual study results were then meta-analyzed. Results The albuminuria response to one dose of RAASi or NSAIDs positively correlated with the response to a higher dose of the same drug (r = 0.72; 95% confidence interval [95% CI], 0.66 to 0.78), changes within the same class of RAASi or NSAIDs (r = 0.54; 95% CI, 0.35 to 0.68), changes between RAASi and NSAIDs (r = 0.44; 95% CI, 0.16 to 0.66), and changes from high to moderately low salt intake (r = 0.36; 95% CI, 0.22 to 0.48). Results were similar when the individual systolic BP and potassium responses were analyzed, and were consistent in patients with and without diabetes. Conclusions Individuals who show a poor response to one dose or type of RAASi also show a poor response to higher doses, other types of RAASi or NSAIDs, or a reduction in dietary salt intake. Whether other drugs or drug combinations targeting pathways beyond the renin-angiotensin-aldosterone system and prostaglandins would improve the individual poor response requires further study
AB - Background and objectives In the treatment of CKD, individual patients show a wide variation in their response to many drugs, including renin-angiotensin-aldosterone system inhibitors (RAASi). To investigate whether therapy resistance to RAASi can be overcome by uptitrating the dose of drug, changing the mode of intervention (with drugs from similar or different classes), or lowering dietary sodium intake, we meta-analyzed individual responses to different modes of interventions. Design, setting, participants, & measurements Randomized crossover trials were analyzed to assess correlation of individual responses to RAASi and nonsteroidal anti-inflammatory drugs (NSAIDs; n = 395 patients). Included studies compared the antialbuminuric effect of uptitrating the dose of RAASi (n = 10 studies) and NSAIDs (n = 1), changing within the same class of RAASi (e.g., angiotensin-converting enzyme inhibition to angiotensin receptor blockers; n = 5) or NSAIDs (n = 1), changing from RAASi to NSAIDs (n = 2), and changing from high to low sodium intake (n = 5). A two-stage meta-analysis was conducted: Deming regression was conducted in each study to assess correlations in response, and individual study results were then meta-analyzed. Results The albuminuria response to one dose of RAASi or NSAIDs positively correlated with the response to a higher dose of the same drug (r = 0.72; 95% confidence interval [95% CI], 0.66 to 0.78), changes within the same class of RAASi or NSAIDs (r = 0.54; 95% CI, 0.35 to 0.68), changes between RAASi and NSAIDs (r = 0.44; 95% CI, 0.16 to 0.66), and changes from high to moderately low salt intake (r = 0.36; 95% CI, 0.22 to 0.48). Results were similar when the individual systolic BP and potassium responses were analyzed, and were consistent in patients with and without diabetes. Conclusions Individuals who show a poor response to one dose or type of RAASi also show a poor response to higher doses, other types of RAASi or NSAIDs, or a reduction in dietary salt intake. Whether other drugs or drug combinations targeting pathways beyond the renin-angiotensin-aldosterone system and prostaglandins would improve the individual poor response requires further study
U2 - https://doi.org/10.2215/CJN.00390117
DO - https://doi.org/10.2215/CJN.00390117
M3 - Article
C2 - 29021336
SN - 1046-6673
VL - 12
SP - 1804
EP - 1813
JO - Clinical journal of the American Society of Nephrology
JF - Clinical journal of the American Society of Nephrology
IS - 11
ER -